Aquaculture Healthcare Market Size & Share 2023 to 2032
Market Size by Product (Drug, Vaccines, Medicated Feed Additives), by Species (Fish, Crustaceans), by Infections (Bacterial Infections, Viral Infections, Fungal Infections) by Route of Administration, by Distribution Channel & Forecast.Download Free PDF
Report Content
Chapter 1 Methodology & Scope
1.1 Methodology
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Public sources
Chapter 2 Executive Summary
2.1 Aquaculture healthcare industry 3600 synopsis, 2018-2032
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Species trends
2.1.4 Infection trends
2.1.5 Route of administration trends
2.1.6 Distribution channel trends
2.1.7 Regional trends
Chapter 3 Aquaculture Healthcare Industry Insights
3.1 Industry segmentation
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 I Increasing demand for fish protein across the world
3.2.1.2 Growing incidence of diseases and parasites in farmed fish
3.2.1.3 Growing R&D efforts by key market players to bring new solutions for aquaculture healthcare
3.2.2 Industry pitfalls & challenges
3.2.2.1 Aversion to farmed fish due to health concerns
3.2.2.2 Lack of knowledge regarding diseases in aquatic animals
3.2.2.3 Concerns over growing antibiotic resistance due to widespread use
3.3 Growth potential analysis
3.4 COVID-19 impact analysis
3.5 Regulatory scenario
3.6 Porter’s analysis
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power Buyers
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2021
4.1 Introduction
4.2 Company market share, 2021
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
Chapter 5 Aquaculture Healthcare Market, By Product
5.1 Key segment trends
5.2 Drugs
5.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.2 Parasiticides
5.2.2.1 Market size, by region, 2018-2032 (USD Million)
5.2.3 Anti-inflammatory
5.2.3.1 Market size, by region, 2018-2032 (USD Million)
5.2.4 Anti-infectives
5.2.4.1 Market size, by region, 2018-2032 (USD Million)
5.2.5 Others
5.2.5.1 Market size, by region, 2018-2032 (USD Million)
5.3 Vaccines
5.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.2 Modified live vaccines [MLV]
5.3.2.1 Market size, by region, 2018-2032 (USD Million)
5.3.3 Killed inactivated vaccines
5.3.3.1 Market size, by region, 2018-2032 (USD Million)
5.3.4 Others
5.3.4.1 Market size, by region, 2018-2032 (USD Million)
5.4 Feed additives
5.4.1 Market size, by region, 2018-2032 (USD Million)
5.4.2 Antibiotics
5.4.2.1 Market size, by region, 2018-2032 (USD Million)
5.4.3 Vitamins
5.4.3.1 Market size, by region, 2018-2032 (USD Million)
5.4.4 Amino acids
5.4.4.1 Market size, by region, 2018-2032 (USD Million)
5.4.5 Enzymes
5.4.5.1 Market size, by region, 2018-2032 (USD Million)
5.4.6 Antioxidants
5.4.6.1 Market size, by region, 2018-2032 (USD Million)
5.4.7 Prebiotics and probiotics
5.4.7.1 Market size, by region, 2018-2032 (USD Million)
5.4.8 Minerals
5.4.8.1 Market size, by region, 2018-2032 (USD Million)
5.4.9 Hormones
5.4.9.1 Market size, by region, 2018-2032 (USD Million)
5.4.10 Others
5.4.10.1 Market size, by region, 2018-2032 (USD Million)
Chapter 6 Aquaculture Healthcare Market, By Species
6.1 Key segment trends
6.2 Fishes
6.2.1 Market size, by region, 2018-2032 (USD Million)
6.2.2 Freshwater species
6.2.2.1 Market size, by region, 2018-2032 (USD Million)
6.2.2.2 Tilapia
6.2.2.2.1 Market size, by region, 2018-2032 (USD Million)
6.2.2.3 Carps
6.2.2.3.1 Market size, by region, 2018-2032 (USD Million)
6.2.2.4 Others
6.2.2.4.1 Market size, by region, 2018-2032 (USD Million)
6.2.3 Marine species
6.2.3.1 Market size, by region, 2018-2032 (USD Million)
6.2.3.2 Seabass seabream
6.2.3.2.1 Market size, by region, 2018-2032 (USD Million)
6.2.3.3 Turbot
6.2.3.3.1 Market size, by region, 2018-2032 (USD Million)
6.2.3.4 Others
6.2.3.4.1 Market size, by region, 2018-2032 (USD Million)
6.2.4 Diadromous species
6.2.4.1 Market size, by region, 2018-2032 (USD Million)
6.2.4.2 Salmon
6.2.4.2.1 Market size, by region, 2018-2032 (USD Million)
6.2.4.3 Trout
6.2.4.3.1 Market size, by region, 2018-2032 (USD Million)
6.2.4.4 Others
6.2.4.4.1 Market size, by region, 2018-2032 (USD Million)
6.3 Crustaceans
6.3.1 Market size, by region, 2018-2032 (USD Million)
6.3.2 Prawns
6.3.2.1 Market size, by region, 2018-2032 (USD Million)
6.3.3 Shrimps
6.3.3.1 Market size, by region, 2018-2032 (USD Million)
6.3.4 Others
6.3.4.1 Market size, by region, 2018-2032 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2018-2032 (USD Million)
Chapter 7 Aquaculture Healthcare Market, By Infection
7.1 Key segment trends
7.2 Bacterial infection
7.2.1 Market size, by region, 2018-2032 (USD Million)
7.3 Viral infection
7.3.1 Market size, by region, 2018-2032 (USD Million)
7.4 Parasitic infection
7.4.1 Market size, by region, 2018-2032 (USD Million)
7.5 Fungal infection
7.5.1 Market size, by region, 2018-2032 (USD Million)
Chapter 8 Aquaculture Healthcare Market, By Route of Administration
8.1 Key segment trends
8.2 Oral
8.2.1 Market size, by region, 2018-2032 (USD Million)
8.3 Injectable
8.3.1 Market size, by region, 2018-2032 (USD Million)
8.4 Topical
8.4.1 Market size, by region, 2018-2032 (USD Million)
Chapter 9 Aquaculture Healthcare Market, By Distribution Channel
9.1 Key segment trends
9.2 Distributors
9.2.1 Market size, by region, 2018-2032 (USD Million)
9.3 Online stores
9.3.1 Market size, by region, 2018-2032 (USD Million)
9.4 Retail/Aqua stores
9.4.1 Market size, by region, 2018-2032 (USD Million)
9.5 Others
9.5.1 Market size, by region, 2018-2032 (USD Million)
Chapter 10 Aquaculture Healthcare Market, By Region
10.1 Key regional trends
10.2 North America
10.2.1 Market size, by country, 2018-2032 (USD Million)
10.2.2 Market size, by product, 2018-2032 (USD Million)
10.2.2.1 Market size, by drugs, 2018-2032 (USD Million)
10.2.2.2 Market size, by vaccines, 2018-2032 (USD Million)
10.2.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.2.3 Market size, by species, 2018-2032 (USD Million)
10.2.3.1 Market size, by fishes, 2018-2032 (USD Million)
10.2.3.1.1 Market size, by freshwater species, 2018-2032 (USD Million)
10.2.3.1.2 Market size, by diadromous species, 2018-2032 (USD Million)
10.2.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.2.4 Market size, by infection, 2018-2032 (USD Million)
10.2.5 Market size, by route of administration, 2018-2032 (USD Million)
10.2.6 Market size, by distribution channel, 2018-2032 (USD Million)
10.2.7 U.S.
10.2.7.1 Market size, by product, 2018-2032 (USD Million)
10.2.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.2.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.2.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.2.7.2 Market size, by species, 2018-2032 (USD Million)
10.2.7.2.1 Market size, by fish, 2018-2032 (USD Million)
10.2.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.2.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.2.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.2.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.2.7.3 Market size, by infection, 2018-2032 (USD Million)
10.2.7.4 Market size, by route of administration, 2018-2032 (USD Million)
10.2.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.2.8 Canada
10.2.8.1 Market size, by product, 2018-2032 (USD Million)
10.2.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.2.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.2.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.2.8.2 Market size, by species, 2018-2032 (USD Million)
10.2.8.2.1 Market size, by fish, 2018-2032 (USD Million)
10.2.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.2.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.2.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.2.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.2.8.3 Market size, by infection, 2018-2032 (USD Million)
10.2.8.4 Market size, by route of administration, 2018-2032 (USD Million)
10.2.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3 Europe
10.3.1 Market size, by country, 2018-2032 (USD Million)
10.3.2 Market size, by product, 2018-2032 (USD Million)
10.3.2.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.2.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.3 Market size, by species, 2018-2032 (USD Million)
10.3.3.1 Market size, by fishes, 2018-2032 (USD Million)
10.3.3.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.3.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.3.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.4 Market size, by infection, 2018-2032 (USD Million)
10.3.5 Market size, by route of administration, 2018-2032 (USD Million)
10.3.6 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.7 Germany
10.3.7.1 Market size, by product, 2018-2032 (USD Million)
10.3.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.7.2 Market size, by species, 2018-2032 (USD Million)
10.3.7.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.7.3 Market size, by infection, 2018-2032 (USD Million)
10.3.7.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.8 UK
10.3.8.1 Market size, by product, 2018-2032 (USD Million)
10.3.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.8.2 Market size, by species, 2018-2032 (USD Million)
10.3.8.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.8.3 Market size, by infection, 2018-2032 (USD Million)
10.3.8.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.9 France
10.3.9.1 Market size, by product, 2018-2032 (USD Million)
10.3.9.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.9.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.9.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.9.2 Market size, by species, 2018-2032 (USD Million)
10.3.9.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.9.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.9.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.9.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.9.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.9.3 Market size, by infection, 2018-2032 (USD Million)
10.3.9.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.9.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.10 Spain
10.3.10.1 Market size, by product, 2018-2032 (USD Million)
10.3.10.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.10.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.10.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.10.2 Market size, by species, 2018-2032 (USD Million)
10.3.10.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.10.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.10.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.10.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.10.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.10.3 Market size, by infection, 2018-2032 (USD Million)
10.3.10.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.10.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.11 Italy
10.3.11.1 Market size, by product, 2018-2032 (USD Million)
10.3.11.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.11.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.11.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.11.2 Market size, by species, 2018-2032 (USD Million)
10.3.11.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.11.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.11.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.11.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.11.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.11.3 Market size, by infection, 2018-2032 (USD Million)
10.3.11.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.11.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.12 Demark
10.3.12.1 Market size, by product, 2018-2032 (USD Million)
10.3.12.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.12.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.12.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.12.2 Market size, by species, 2018-2032 (USD Million)
10.3.12.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.12.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.12.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.12.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.12.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.12.3 Market size, by infection, 2018-2032 (USD Million)
10.3.12.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.12.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.13 Iceland
10.3.13.1 Market size, by product, 2018-2032 (USD Million)
10.3.13.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.13.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.13.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.13.2 Market size, by species, 2018-2032 (USD Million)
10.3.13.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.13.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.13.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.13.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.13.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.13.3 Market size, by infection, 2018-2032 (USD Million)
10.3.13.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.13.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.14 Ireland
10.3.14.1 Market size, by product, 2018-2032 (USD Million)
10.3.14.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.14.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.14.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.14.2 Market size, by species, 2018-2032 (USD Million)
10.3.14.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.14.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.14.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.14.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.14.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.14.3 Market size, by infection, 2018-2032 (USD Million)
10.3.14.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.14.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.15 Norway
10.3.15.1 Market size, by product, 2018-2032 (USD Million)
10.3.15.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.15.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.15.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.15.2 Market size, by species, 2018-2032 (USD Million)
10.3.15.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.15.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.15.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.15.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.15.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.15.3 Market size, by infection, 2018-2032 (USD Million)
10.3.15.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.15.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.16 Poland
10.3.16.1 Market size, by product, 2018-2032 (USD Million)
10.3.16.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.16.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.16.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.16.2 Market size, by species, 2018-2032 (USD Million)
10.3.16.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.16.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.16.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.16.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.16.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.16.3 Market size, by infection, 2018-2032 (USD Million)
10.3.16.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.16.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.3.17 Turkey
10.3.17.1 Market size, by product, 2018-2032 (USD Million)
10.3.17.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.3.17.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.3.17.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.3.17.2 Market size, by species, 2018-2032 (USD Million)
10.3.17.2.1 Market size, by fish, 2018-2032 (USD Million)
10.3.17.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.3.17.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.3.17.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.3.17.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.3.17.3 Market size, by infection, 2018-2032 (USD Million)
10.3.17.4 Market size, by route of administration, 2018-2032 (USD Million)
10.3.17.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4 Asia Pacific
10.4.1 Market size, by country, 2018-2032 (USD Million)
10.4.2 Market size, by product, 2018-2032 (USD Million)
10.4.2.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.2.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.3 Market size, by species, 2018-2032 (USD Million)
10.4.3.1 Market size, by fishes, 2018-2032 (USD Million)
10.4.3.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.3.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.3.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.4 Market size, by infection, 2018-2032 (USD Million)
10.4.5 Market size, by route of administration, 2018-2032 (USD Million)
10.4.6 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.7 China
10.4.7.1 Market size, by product, 2018-2032 (USD Million)
10.4.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.7.2 Market size, by species, 2018-2032 (USD Million)
10.4.7.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.7.3 Market size, by infection, 2018-2032 (USD Million)
10.4.7.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.8 Vietnam
10.4.8.1 Market size, by product, 2018-2032 (USD Million)
10.4.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.8.2 Market size, by species, 2018-2032 (USD Million)
10.4.8.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.8.3 Market size, by infection, 2018-2032 (USD Million)
10.4.8.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.9 Indonesia
10.4.9.1 Market size, by product, 2018-2032 (USD Million)
10.4.9.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.9.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.9.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.9.2 Market size, by species, 2018-2032 (USD Million)
10.4.9.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.9.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.9.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.9.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.9.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.9.3 Market size, by infection, 2018-2032 (USD Million)
10.4.9.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.9.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.10 India
10.4.10.1 Market size, by product, 2018-2032 (USD Million)
10.4.10.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.10.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.10.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.10.2 Market size, by species, 2018-2032 (USD Million)
10.4.10.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.10.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.10.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.10.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.10.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.10.3 Market size, by infection, 2018-2032 (USD Million)
10.4.10.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.10.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.11 Thailand
10.4.11.1 Market size, by product, 2018-2032 (USD Million)
10.4.11.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.11.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.11.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.11.2 Market size, by species, 2018-2032 (USD Million)
10.4.11.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.11.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.11.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.11.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.11.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.11.3 Market size, by infection, 2018-2032 (USD Million)
10.4.11.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.11.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.12 Bangladesh
10.4.12.1 Market size, by product, 2018-2032 (USD Million)
10.4.12.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.12.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.12.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.12.2 Market size, by species, 2018-2032 (USD Million)
10.4.12.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.12.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.12.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.12.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.12.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.12.3 Market size, by infection, 2018-2032 (USD Million)
10.4.12.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.12.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.13 Philippines
10.4.13.1 Market size, by product, 2018-2032 (USD Million)
10.4.13.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.13.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.13.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.13.2 Market size, by species, 2018-2032 (USD Million)
10.4.13.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.13.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.13.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.13.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.13.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.13.3 Market size, by infection, 2018-2032 (USD Million)
10.4.13.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.13.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.14 Australia
10.4.14.1 Market size, by product, 2018-2032 (USD Million)
10.4.14.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.14.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.14.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.14.2 Market size, by species, 2018-2032 (USD Million)
10.4.14.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.14.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.14.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.14.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.14.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.14.3 Market size, by infection, 2018-2032 (USD Million)
10.4.14.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.14.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.4.15 New Zealand
10.4.15.1 Market size, by product, 2018-2032 (USD Million)
10.4.15.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.4.15.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.4.15.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.4.15.2 Market size, by species, 2018-2032 (USD Million)
10.4.15.2.1 Market size, by fish, 2018-2032 (USD Million)
10.4.15.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.4.15.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.4.15.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.4.15.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.4.15.3 Market size, by infection, 2018-2032 (USD Million)
10.4.15.4 Market size, by route of administration, 2018-2032 (USD Million)
10.4.15.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.5 Latin America
10.5.1 Market size, by country, 2018-2032 (USD Million)
10.5.2 Market size, by product, 2018-2032 (USD Million)
10.5.2.1 Market size, by drugs, 2018-2032 (USD Million)
10.5.2.2 Market size, by vaccines, 2018-2032 (USD Million)
10.5.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.5.3 Market size, by species, 2018-2032 (USD Million)
10.5.3.1 Market size, by fishes, 2018-2032 (USD Million)
10.5.3.1.1 Market size, by freshwater species, 2018-2032 (USD Million)
10.5.3.1.2 Market size, by diadromous species, 2018-2032 (USD Million)
10.5.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.5.4 Market size, by infection, 2018-2032 (USD Million)
10.5.5 Market size, by route of administration, 2018-2032 (USD Million)
10.5.6 Market size, by distribution channel, 2018-2032 (USD Million)
10.5.7 Brazil
10.5.7.1 Market size, by product, 2018-2032 (USD Million)
10.5.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.5.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.5.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.5.7.2 Market size, by species, 2018-2032 (USD Million)
10.5.7.2.1 Market size, by fish, 2018-2032 (USD Million)
10.5.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.5.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.5.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.5.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.5.7.3 Market size, by infection, 2018-2032 (USD Million)
10.5.7.4 Market size, by route of administration, 2018-2032 (USD Million)
10.5.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.5.8 Mexico
10.5.8.1 Market size, by product, 2018-2032 (USD Million)
10.5.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.5.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.5.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.5.8.2 Market size, by species, 2018-2032 (USD Million)
10.5.8.2.1 Market size, by fish, 2018-2032 (USD Million)
10.5.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.5.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.5.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.5.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.5.8.3 Market size, by infection, 2018-2032 (USD Million)
10.5.8.4 Market size, by route of administration, 2018-2032 (USD Million)
10.5.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.5.9 Chile
10.5.9.1 Market size, by product, 2018-2032 (USD Million)
10.5.9.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.5.9.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.5.9.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.5.9.2 Market size, by species, 2018-2032 (USD Million)
10.5.9.2.1 Market size, by fish, 2018-2032 (USD Million)
10.5.9.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.5.9.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.5.9.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.5.9.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.5.9.3 Market size, by infection, 2018-2032 (USD Million)
10.5.9.4 Market size, by route of administration, 2018-2032 (USD Million)
10.5.9.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.6 Middle East and Africa
10.6.1 Market size, by country, 2018-2032 (USD Million)
10.6.2 Market size, by product, 2018-2032 (USD Million)
10.6.2.1 Market size, by drugs, 2018-2032 (USD Million)
10.6.2.2 Market size, by vaccines, 2018-2032 (USD Million)
10.6.2.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.6.3 Market size, by species, 2018-2032 (USD Million)
10.6.3.1 Market size, by fishes, 2018-2032 (USD Million)
10.6.3.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.6.3.1.2 Market size, by marine, 2018-2032 (USD Million)
10.6.3.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.6.3.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.6.4 Market size, by infection, 2018-2032 (USD Million)
10.6.5 Market size, by route of administration, 2018-2032 (USD Million)
10.6.6 Market size, by distribution channel, 2018-2032 (USD Million)
10.6.7 Iran
10.6.7.1 Market size, by product, 2018-2032 (USD Million)
10.6.7.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.6.7.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.6.7.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.6.7.2 Market size, by species, 2018-2032 (USD Million)
10.6.7.2.1 Market size, by fish, 2018-2032 (USD Million)
10.6.7.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.6.7.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.6.7.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.6.7.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.6.7.3 Market size, by infection, 2018-2032 (USD Million)
10.6.7.4 Market size, by route of administration, 2018-2032 (USD Million)
10.6.7.5 Market size, by distribution channel, 2018-2032 (USD Million)
10.6.8 Egypt
10.6.8.1 Market size, by product, 2018-2032 (USD Million)
10.6.8.1.1 Market size, by drugs, 2018-2032 (USD Million)
10.6.8.1.2 Market size, by vaccines, 2018-2032 (USD Million)
10.6.8.1.3 Market size, by medicated feed additives, 2018-2032 (USD Million)
10.6.8.2 Market size, by species, 2018-2032 (USD Million)
10.6.8.2.1 Market size, by fish, 2018-2032 (USD Million)
10.6.8.2.1.1 Market size, by freshwater, 2018-2032 (USD Million)
10.6.8.2.1.2 Market size, by marine, 2018-2032 (USD Million)
10.6.8.2.1.3 Market size, by diadromous, 2018-2032 (USD Million)
10.6.8.2.2 Market size, by crustaceans, 2018-2032 (USD Million)
10.6.8.3 Market size, by infection, 2018-2032 (USD Million)
10.6.8.4 Market size, by route of administration, 2018-2032 (USD Million)
10.6.8.5 Market size, by distribution channel, 2018-2032 (USD Million)
Chapter 11 Company Profiles
11.1 Merck
11.1.1 Business overview
11.1.2 Financial data
11.1.3 Service landscape
11.1.4 Strategic outlook
11.1.5 SWOT analysis
11.2 Archer Daniels Midland Company
11.2.1 Business overview
11.2.2 Financial data
11.2.3 Service landscape
11.2.4 Strategic outlook
11.2.5 SWOT analysis
11.3 Benchmark PLC
11.3.1 Business overview
11.3.2 Financial data
11.3.3 Service landscape
11.3.4 Strategic outlook
11.3.5 SWOT analysis
11.4 Ceva Sante
11.4.1 Business overview
11.4.2 Financial data
11.4.3 Service landscape
11.4.4 Strategic outlook
11.4.5 SWOT analysis
11.5 Phibro Animal Health Corporation
11.5.1 Business overview
11.5.2 Financial data
11.5.3 Service landscape
11.5.4 Strategic outlook
11.5.5 SWOT analysis
11.6 Elanco
11.6.1 Business overview
11.6.2 Financial data
11.6.3 Service landscape
11.6.4 Strategic outlook
11.6.5 SWOT analysis
11.7 Vetoquinol S A
11.7.1 Business overview
11.7.2 Financial data
11.7.3 Service landscape
11.7.4 Strategic outlook
11.7.5 SWOT analysis
11.8 Virbac
11.8.1 Business overview
11.8.2 Financial data
11.8.3 Service landscape
11.8.4 Strategic outlook
11.8.5 SWOT analysis
11.9 Zeal Aqua
11.9.1 Business overview
11.9.2 Financial data
11.9.3 Service landscape
11.9.4 Strategic outlook
11.9.5 SWOT analysis
11.10 Zoetis LLC
11.10.1 Business overview
11.10.2 Financial data
11.10.3 Service landscape
11.10.4 Strategic outlook
11.10.5 SWOT analysis
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at [email protected]
Base Year: 2022
Companies covered: 10
Tables & Figures: 921
Countries covered: 27
Pages: 420
Download Free PDF
Base Year: 2022
Companies covered: 10
Tables & Figures: 921
Countries covered: 27
Pages: 420
Download Free PDF
Share Content
Add Citations
Mariam Faizullabhoy. 2022, December. Aquaculture Healthcare Market - By Product (Drug, Vaccines, Medicated Feed Additives), By Species (Fish, Crustaceans), By Infections (Bacterial Infections, Viral Infections, Fungal Infections) By Route of Administration, By Distribution Channel & Forecast, 2023-2032 (Report ID: GMI4536). Global Market Insights Inc. Retrieved April 28, 2026, from https://www.gminsights.com/toc/details/aquaculture-healthcare-market

Aquaculture Healthcare Market
Get a free sample of this report
Aquaculture Healthcare Market Size
Aquaculture Healthcare Market size was valued at over USD 900 million in 2022 and is set to depict more than 8.5% CAGR over 2023-2032 driven by the burgeoning demand for fish protein across the globe.
Population growth is resulting in a greater demand for quality nutrition and an upsurge in fish consumption is a major factor accelerating the industry development. A growing number of people are relying on aquaculture to offer a sustainable supply of fish since natural fish sources cannot support this rate of fishing. In addition, the demand for healthcare solutions is likely to be bolstered by the increasing number of aquaculture farms.
Lack of knowledge about diseases in aquatic animals may limit revenue growth
Market development is expected to be hampered by a lack of knowledge about epidemiology and illness treatment for aquatic animals in the short term. Aquaculture has always trailed behind other livestock; hence, there is a lack of research on aquaculture health, resulting in fewer healthcare options, which may further limit product uptake. However, growing initiatives by industry participants and retail aqua stores to raise awareness among fish farmers about the various benefits associated with aquaculture healthcare solutions, as well as the mounting availability of novel solutions, may help them overcome this constraint through the projected period.
Aquaculture Healthcare Market Analysis
In terms of product, the aquaculture healthcare market share from the medicated feed additives segment is foreseen to record significant growth at over 10% CAGR through 2032. The segment is further classified into topical treatments, amino acids, antioxidants, enzymes, antibiotics, minerals, hormones, prebiotics and probiotics, and vitamins. Medicated feed additives include medications or antibiotics that assist aquaculture farmers in lowering the risks of illnesses, infections, or diseases in aquatic creatures as well as in increasing the nutritional value and quality of food, which is expected to positively influence their uptake through 2032.
On the basis of species, the fish segment of the aquaculture healthcare market accounted for over USD 775 million in revenue in 2022, the report claims. The need for aquaculture healthcare solutions has increased due to the rising demand for high-quality fish proteins, which is slated to boost segment development. The flourishing fish farming sector, which requires better fish productivity, is projected to be a significant driver impelling the business growth through 2032.
Aquaculture healthcare market is bifurcated by infection into bacterial infection, viral infection, parasitic infection, and fungal infection. The parasitic infection segment is foreseen to surpass USD 450 million by 2032. The increased vulnerability of aquatic species to parasites, such as sea lice and sea fleas has resulted in an upsurge in the demand for parasitic infection medications. For instance, salmon are highly vulnerable to sea lice infection. Furthermore, the development of novel treatments and innovative solutions to treat these infections is expected to stimulate segment trends.
As per the route of administration, the aquaculture healthcare market is segregated based on oral, topical, and injectable. The topical segment is anticipated to register more than USD 735 million by 2032, the study cites. Topical therapeutics lower the handling stress for fish and improve the outcomes, making them a highly popular alternative solution among fish farmers. Additionally, smaller fish and fry require topical immunizations before they can be vaccinated, boosting the demand for topical treatments, which is speculated to support segment expansion through 2032.
The aquaculture healthcare market is segmented based on distribution channels into retail/aqua stores, distributors, online stores, and others. The retail/aqua stores segment is estimated to generate more than USD 460 million in revenue by 2032 owing to the access to numerous therapeutic solutions at retail stores. The increasing availability of specialty products stocked for aquatic animals at aqua stores is estimated to fuel segment expansion.
Asia Pacific aquaculture healthcare market is poised to grow at more than 9.5% CAGR through the forecast timeline. Several APAC nations, including Thailand, India, China, and Indonesia, are among the world's largest producers of crustaceans, resulting in growing regional demand for crustacean therapeutic products. Furthermore, surging awareness among fish farmers about the significance of aquaculture healthcare is likely to contribute to increased product adoption, thereby propelling regional market outlook.
Aquaculture Healthcare Market Share
Enterprises involved in the aquaculture healthcare market include :
These companies are focused on reaching untapped markets to increase sales. For instance, in September 2020, Virbac, an animal health pharmaceutical firm, acquired a variety of tilapia vaccines from Ictyogroup, an animal health company specializing in R&D biology, and also signed a deal with Ictyogroup for the development of additional tilapia vaccines for the Aqua Virbac division.
COVID-19 Impact
The COVID-19 outbreak negatively impacted virtually all enterprises and caused economic activities to cease. The aquaculture and fishing sectors have been overlooked or disregarded while discussing measures to combat the grave conditions of the COVID-19 pandemic. The aquaculture healthcare industry's revenue was thus hampered during the pandemic owing to the low demand for aquaculture animals, resulting in a declining requirement for treatments for aquatic animals. However, in the post-pandemic scenario, the market is expanding due to the rising need for nutrient-dense food products, which is projected to supplement the business growth.
The aquaculture healthcare market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
By Product
By Species
By Infection
By Route of Administration
By Distribution Channel
The above information is provided for the following regions and countries: